Oncology Pharma Inc logo

ONPH - Oncology Pharma Inc Share Price

$0.009 -0.0  -4.1%

Last Trade - 28/05/20

Sector
Healthcare
Size
Micro Cap
Market Cap £1.20m
Enterprise Value £1.69m
Revenue £24.1k
Position in Universe th / 6361
Bullish
Bearish
Unlock ONPH Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Financial Summary
FINANCIAL BRIEF: : For the six months ended 30 September 2013, Oncology Pharma Inc revenues increased from $0K to $19K. Net loss totaled $22M vs. income of $0K. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net loss reflects Stock based compensation increase from $0K to $22M (expense), General and administrative expenses increase from $0K to $43K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

ONPH Revenue Unlock ONPH Revenue

Net Income

ONPH Net Income Unlock ONPH Revenue

Normalised EPS

ONPH Normalised EPS Unlock ONPH Revenue

PE Ratio Range

ONPH PE Ratio Range Unlock ONPH Revenue

Dividend Yield Range

ONPH Dividend Yield Range Unlock ONPH Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
ONPH EPS Forecasts Unlock ONPH Revenue
Profile Summary

Oncology Pharma Inc. is an oncology company. The Company is focused on developing, manufacturing and commercialization of therapeutics. The Company’s portfolio includes Nanosmart Pharmaceuticals and Tulynode. Tulynode is an autologous cellular immune-therapy extracorporeal device. The Company’s NanoSmart's platform technology is a human-derived, antinuclear antibody (ANA) that targets areas of necrosis present in solid tumors.

Directors
Last Annual March 31st, 2013
Last Interim September 30th, 2013
Incorporated June 5, 2013
Public Since April 8, 1994
No. of Shareholders: n/a
No. of Employees: 1
Sector Healthcare
Industry Pharmaceuticals
Index
Exchange OTC Markets Group
Shares in Issue 149,896,092
Free Float (0.0%)
Eligible for
ISAs
SIPPs
ONPH Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for ONPH
Upcoming Events for ONPH
Frequently Asked Questions for Oncology Pharma Inc
What is the Oncology Pharma Inc share price?

As of 28/05/20, shares in Oncology Pharma Inc are trading at $0.009, giving the company a market capitalisation of £1.20m. This share price information is delayed by 15 minutes.

How has the Oncology Pharma Inc share price performed this year?

Shares in Oncology Pharma Inc are currently trading at $0.009 and the price has moved by -3.92% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Oncology Pharma Inc price has moved by -4.53% over the past year.

What are the analyst and broker recommendations for Oncology Pharma Inc?

There are no analysts currently covering Oncology Pharma Inc.

When will Oncology Pharma Inc next release its financial results?

Oncology Pharma Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2014-09-30
What is the Oncology Pharma Inc dividend yield?

Oncology Pharma Inc does not currently pay a dividend.

Does Oncology Pharma Inc pay a dividend?

Oncology Pharma Inc does not currently pay a dividend.

When does Oncology Pharma Inc next pay dividends?

Oncology Pharma Inc does not currently pay a dividend.

How do I buy Oncology Pharma Inc shares?

To buy shares in Oncology Pharma Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Oncology Pharma Inc?

Shares in Oncology Pharma Inc are currently trading at $0.009, giving the company a market capitalisation of £1.20m.

Where are Oncology Pharma Inc shares listed? Where are Oncology Pharma Inc shares listed?

Here are the trading details for Oncology Pharma Inc:

Country of listing: United States
Exchange: OTC
Ticker Symbol: ONPH
What kind of share is Oncology Pharma Inc?

We were not able to load our ranking data for Oncology Pharma Inc

Is there a Oncology Pharma Inc share price forecast 2020?

We were not able to load any forecast data for Oncology Pharma Inc.

How can I tell whether the Oncology Pharma Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Oncology Pharma Inc. Over the past six months, the relative strength of its shares against the market has been -57.31%. At the current price of $0.009, shares in Oncology Pharma Inc are trading at -61.45% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Oncology Pharma Inc PE Ratio?

We were not able to find PE ratio data for Oncology Pharma Inc.

Who are the key directors of Oncology Pharma Inc?

We were unable to find the directors for Oncology Pharma Inc.

Who are the major shareholders of Oncology Pharma Inc?

Here are the top five shareholders of Oncology Pharma Inc based on the size of their shareholding:

Similar to ONPH
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.